dc.contributor.author |
Ocan, Moses |
|
dc.contributor.author |
Aono, Mary |
|
dc.contributor.author |
Bukirwa, Clare |
|
dc.contributor.author |
Luyinda, Emmanuel |
|
dc.contributor.author |
Ochwo, Cathy |
|
dc.contributor.author |
Nsambu, Elastus |
|
dc.contributor.author |
Namugonza, Stella |
|
dc.contributor.author |
Makoba, Joseph |
|
dc.contributor.author |
Kandaruku, Enock |
|
dc.contributor.author |
Muyende, Hannington |
|
dc.contributor.author |
Nakawunde, Aida |
|
dc.date.accessioned |
2021-01-01T21:57:53Z |
|
dc.date.available |
2021-01-01T21:57:53Z |
|
dc.date.issued |
2017 |
|
dc.identifier.issn |
1471-2458 |
|
dc.identifier.uri |
http://combine.alvar.ug/handle/1/48070 |
|
dc.description.abstract |
Background: Medicines are commonly accessed and used for management of illness in children without a prescription. This potentially increases the risk of unwanted treatment outcomes. We investigated medicine use practices in management of symptoms of acute upper respiratory tract infections among children (<= 12 years) in households in Nakawa division, Kampala city. Methods: This was a cross-sectional study conducted among 390 randomly selected children. Data on use of medicines in children (<= 12 years) during recent episode of acute upper respiratory tract infection was collected from their care takers using an interviewer administered questionnaire. A recall period of two weeks (14 days) was used in during data collection. Results: The prevalence of giving children non-prescription antimicrobial medicines was 44.8% (38.3-52.2). The most common disease symptoms that the children reportedly had included flu, 84.9% (331/390), cough, 83.1% (324/390), and undefined fever, 69.7% (272/390). Medicines commonly given to children included, paracetamol 53. 1% (207/390), Coartem 29.7% (116/390), cough linctus 20.8% (81/390), amoxicillin 18.9% (74/390), Co-trimoxazole 18. 5% (72/390), and diphenhydramine 15.4% (60/390). The major sources of medicines given to the children was hospital/clinic, 57.26% (223/390). Most of the children, 81% were given more than one medicine at a time. The majority, 62.3% (243/390) of the care takers who gave the children medicine during the recent illness were not aware of any medicine (s) that should not be given to children. The predictors of non-prescription use of antimicrobial medicines in managing symptoms of acute upper respiratory tract infections in children included, medicines obtained from drug shop (PR: 1.45, CI: 1.14-1.85), medicines at home (PR: 1.8, CI: 0.83-1.198) and type of medicine (antimalarial) (PR: 2.8, CI: 1.17-6.68). Conclusion: Children are commonly given multiple medicines during episodes of acute upper respiratory tract infections with most antimicrobial agents accessed and used without a prescription in Kampala city, Uganda. |
|
dc.description.sponsorship |
MESAU-MEPI consortium - Office of the U.S. Global AIDS Coordinator (OGAC) [5R24TW008886] |
|
dc.description.sponsorship |
National Institute of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA |
|
dc.description.sponsorship |
Health Resources and Services Administration (HRSA)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) |
|
dc.description.sponsorship |
FOGARTY INTERNATIONAL CENTERUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC) [R24TW008886, R24TW008886, R24TW008886, R24TW008886, R24TW008886, R24TW008886, R24TW008886, R24TW008886] Funding Source: NIH RePORTER |
|
dc.language |
English |
|
dc.publisher |
BIOMED CENTRAL LTD |
|
dc.relation.ispartof |
BMC Public Health |
|
dc.subject |
Upper Respiratory Tract Infections |
|
dc.subject |
Self-Medication |
|
dc.subject |
Antimicrobial Agents |
|
dc.subject |
Kampala |
|
dc.title |
Medicine use practices in management of symptoms of acute upper respiratory tract infections in children (<= 12 years) in Kampala city, Uganda |
|
dc.type |
Article |
|
dc.identifier.isi |
000411414700003 |
|
dc.identifier.doi |
10.1186/s12889-017-4770-1 |
|
dc.identifier.pmid |
28934933 |
|
dc.publisher.city |
LONDON |
|
dc.publisher.address |
236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND |
|
dc.identifier.volume |
17 |
|
dc.subject.wc |
Public, Environmental & Occupational Health |
|
dc.subject.sc |
Public, Environmental & Occupational Health |
|
dc.description.oa |
DOAJ Gold |
|
dc.description.oa |
Green Published |
|
dc.description.pages |
8 |
|
dc.subject.kwp |
Drug-Use |
|
dc.subject.kwp |
Prescription |
|
dc.subject.kwp |
Antibiotics |
|
dc.subject.kwp |
Population |
|
dc.subject.kwp |
Medication |
|
dc.subject.kwp |
Agenda |
|
dc.subject.kwp |
Adults |
|
dc.identifier.articleno |
732 |
|
dc.description.affiliation |
Makerere Univ, Dept Med, Coll Hlth Sci, POB 7072, Kampala, Uganda |
|
dc.description.affiliation |
Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, POB 7072, Kampala, Uganda |
|
dc.description.affiliation |
Makerere Univ, Dept Pharm, Coll Hlth Sci, POB 7072, Kampala, Uganda |
|
dc.description.email |
ocanmoses@gmail.com |
|
dc.description.corr |
Ocan, M (corresponding author), Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, POB 7072, Kampala, Uganda. |
|